問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
陳威君
下載
2025-07-01 - 2029-06-30
Condition/Disease
Cervical Intraepithelial Neoplasia Grade 2/3、Human Papilloma Virus Infection Type 16
Test Drug
liquid
Participate Sites9Sites
Recruiting9Sites
2025-10-01 - 2034-05-31
Cervical Cancer
Injectables Injectables Injectables
Participate Sites5Sites
Recruiting5Sites
2023-07-01 - 2030-02-28
Participate Sites11Sites
Not yet recruiting1Sites
Recruiting10Sites
2023-06-01 - 2027-12-31
2020-08-01 - 2028-06-30
Participate Sites6Sites
Recruiting6Sites
2022-07-01 - 2028-12-31
2025-11-19 - 2030-06-30
Participate Sites10Sites
2024-04-01 - 2029-12-31
Participate Sites3Sites
Recruiting3Sites
2024-12-01 - 2028-12-31
Participate Sites7Sites
Recruiting7Sites
2024-12-01 - 2029-03-31
Not yet recruiting4Sites
Recruiting2Sites
全部
